MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholler, A.
Right arrow Articles by Reiners, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholler, A.
Right arrow Articles by Reiners, J. J.

Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole

A Scholler, NJ Hong, P Bischer and JJ Reiners

Institute of Chemical Toxicology, Wayne State University, Detroit, Michigan 48201.

Cultured murine hepatoma 1c1c7 cells were treated with either the actin filament-disrupting drug cytochalasin D or the microtubule inhibitors colchicine and nocadazole (NOC) to assess the role of the cytoskeleton in the process of cytochrome P450 Cyp1a-1 induction. Indirect fluorescence analyses demonstrated that microtubule or actin networks were disrupted within 1 hr of treatment and remained altered as long as cultures were maintained in the presence of the drugs. Treatment of cultures with cytochalasin D, colchicine, or NOC for 1 hr before the addition of dibenz[a,c]anthracene had no effect of Cyp1a-1 induction, as monitored by measurements of CYP1A1 mRNA. Pretreatment with NOC for > or = 18 hr produced populations of cells that had either a flat or rounded morphology. Both populations, when isolated 20-24 hr after NOC treatment, were arrested in the G2/M phase of the cell cycle (83-98% in G2/M versus approximately 7-10% in nontreated or solvent-treated cultures). Cyp1a-1 induction was suppressed in both of these populations, as monitored by measurement of CYP1A1 mRNA content (reductions of > 68%), 7-ethoxyresorufin O-deethylase activity (reductions of > 80%), or microsomal CYP1A1 protein content (reductions of > 80%). In contrast, overall [3H]leucine incorporation into protein was not affected. Cytosol prepared from these NOC-treated cultures bound approximately 39% of the radiolabeled 2,3,7,8-tetrachlorodibenzo- p-dioxin bound by cytosol isolated from solvent-treated cultures. Nuclear extracts prepared from cultures treated with NOC for 20-24 hr before in vivo exposure to inducer and cytoplasmic extracts isolated from similarly NOC-treated cultures that were exposed to inducer in vitro demonstrated reductions of > or = 54% and > or = 55%, respectively, in their abilities to bind to DNA, when analyzed by gel retardation analyses using an oligonucleotide corresponding to dioxin- responsive element D of the Cyp1a-1 gene. These studies suggest that ligand-dependent induction of Cyp1a-1 transcription is unaffected by short term disruption of the microfilament or microtubule network. However, long term exposure to microtubule inhibitors causes cells to pause in the G2/M stage of the cell cycle and modulates processes involved in the induction of Cyp1a-1 in these cells.

Volume 45, Issue 5, pp. 944-954, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. R. Dale and S. E. Eltom
Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor
Mol. Pharmacol., November 1, 2006; 70(5): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Guo, R. J. Roman, J. R. Falck, P. A. Edwards, and A. G. Scicli
Human U251 Glioma Cell Proliferation Is Suppressed by HET0016 [N-Hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a Selective Inhibitor of CYP4A
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 526 - 533.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Joiakim, P. A. Mathieu, A. A. Elliott, and J. J. Reiners Jr.
Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome
Mol. Pharmacol., October 1, 2004; 66(4): 936 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Petrulis, A. Kusnadi, P. Ramadoss, B. Hollingshead, and G. H. Perdew
The hsp90 Co-chaperone XAP2 Alters Importin beta Recognition of the Bipartite Nuclear Localization Signal of the Ah Receptor and Represses Transcriptional Activity
J. Biol. Chem., January 17, 2003; 278(4): 2677 - 2685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners Jr.
Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-beta . A PROCESS INITIATED BY THE EXOCYTOSIS OF CATHEPSIN B
J. Biol. Chem., April 19, 2002; 277(17): 14829 - 14837.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. P. Santini, S. Myrand, C. Elferink, and J. J. Reiners Jr.
Regulation of Cyp1a1 Induction by Dioxin as a Function of Cell Cycle Phase
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 718 - 728.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Guo and J. J. Reiners Jr
Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines
Carcinogenesis, July 1, 2000; 21(7): 1303 - 1312.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Reiners Jr. and R. E. Clift
Aryl Hydrocarbon Receptor Regulation of Ceramide-induced Apoptosis in Murine Hepatoma 1c1c7 Cells. A FUNCTION INDEPENDENT OF ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR
J. Biol. Chem., January 22, 1999; 274(4): 2502 - 2510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N.-L. Ge and C. J. Elferink
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein. LINKING DIOXIN SIGNALING TO THE CELL CYCLE
J. Biol. Chem., August 28, 1998; 273(35): 22708 - 22713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Hoivik, K. Willett, C. Wilson, and S. Safe
Estrogen Does Not Inhibit 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Effects in MCF-7 and Hepa 1c1c7 Cells
J. Biol. Chem., November 28, 1997; 272(48): 30270 - 30274.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics